CVE-2022-47376 Hardcoded credentials in Alaris Infusion Central

High 7.3 Published Updated

Recoverable passwords in Alaris Infusion Central allow attackers to bypass authentication and potentially access stored personal data.

Exploited in the wild
Not known
Login needed
Any signed-in user
Attackable
Local or same network only
Victim action needed
Not needed
Fix
None listed

What is CVE-2022-47376?

CVE-2022-47376 is a high-severity vulnerability in Alaris Infusion Central, published on 13 Jun 2023. It can only be exploited from the same machine or local network, with no action from the victim.

Official description

The Alaris Infusion Central software, versions 1.1 to 1.3.2, may contain a recoverable password after the installation. No patient health data is stored in the database, although some site installations may choose to store personal data.

Weakness: CWE-522, CWE-257

Which versions are affected by CVE-2022-47376?

It affects 1 product.

Products include Bd Alaris Infusion Central.

How do I fix CVE-2022-47376?

No fix has been published for CVE-2022-47376 yet. Limit exposure of the affected software until one is available.

Is CVE-2022-47376 being exploited?

There is no known exploitation of CVE-2022-47376 in the wild and no public exploit code.

Sources

Also known as GHSA-h3m9-vw67-pc8x.

Is CVE-2022-47376 in your software?

Upload an SBOM and sbomify checks it against every vulnerability here, every day.

Check your SBOMs for free